203 related articles for article (PubMed ID: 28982209)
1. Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model.
Saing S; Haywood P; Duncan JK; Ma N; Cameron AL; Goodall S
ANZ J Surg; 2018 Jun; 88(6):E507-E511. PubMed ID: 28982209
[TBL] [Abstract][Full Text] [Related]
2. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan.
Nishie A; Goshima S; Haradome H; Hatano E; Imai Y; Kudo M; Matsuda M; Motosugi U; Saitoh S; Yoshimitsu K; Crawford B; Kruger E; Ball G; Honda H
Clin Ther; 2017 Apr; 39(4):738-750.e4. PubMed ID: 28363694
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
[TBL] [Abstract][Full Text] [Related]
7. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim MJ; Rinde H; Jonas E
Eur Radiol; 2016 Nov; 26(11):4121-4130. PubMed ID: 26905871
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis.
Schnitzer ML; Buchner J; Biechele G; Grawe F; Ingenerf M; von Münchhausen N; Kaiser CG; Kunz WG; Froelich MF; Schmid-Tannwald C; Rübenthaler J
Eur J Radiol; 2023 Jun; 163():110803. PubMed ID: 37004464
[TBL] [Abstract][Full Text] [Related]
9. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC
Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408
[TBL] [Abstract][Full Text] [Related]
10. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
12. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea.
Lee JM; Kim MJ; Phongkitkarun S; Sobhonslidsuk A; Holtorf AP; Rinde H; Bergmann K
J Med Econ; 2016 Aug; 19(8):759-68. PubMed ID: 27026278
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.
Gazelle GS; Hunink MG; Kuntz KM; McMahon PM; Halpern EF; Beinfeld M; Lester JS; Tanabe KK; Weinstein MC
Ann Surg; 2003 Apr; 237(4):544-55. PubMed ID: 12677152
[TBL] [Abstract][Full Text] [Related]
15. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
[TBL] [Abstract][Full Text] [Related]
16. Children with headache suspected of having a brain tumor: a cost-effectiveness analysis of diagnostic strategies.
Medina LS; Kuntz KM; Pomeroy S
Pediatrics; 2001 Aug; 108(2):255-63. PubMed ID: 11483785
[TBL] [Abstract][Full Text] [Related]
17. Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis.
Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Matsueda K; Saiura A
Ann Surg; 2015 Dec; 262(6):1086-91. PubMed ID: 26010441
[TBL] [Abstract][Full Text] [Related]
18. Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.
Lejeune C; Bismuth MJ; Conroy T; Zanni C; Bey P; Bedenne L; Faivre J; Arveux P; Guillemin F
J Nucl Med; 2005 Dec; 46(12):2020-8. PubMed ID: 16330566
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Kitamura T; Faima Z; Fukushima K; Araki T; Iino H; Mori Y; Fujii H
J Magn Reson Imaging; 2010 Nov; 32(5):1132-40. PubMed ID: 21031519
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Imaging Strategies for Occult Hip Fractures: A Decision and Cost-Effectiveness Analysis.
Yun BJ; Myriam Hunink MG; Prabhakar AM; Heng M; Liu SW; Qudsi R; Raja AS
Acad Emerg Med; 2016 Oct; 23(10):1161-1169. PubMed ID: 27286291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
